France

France country outline

Estimated Number of Current PrEP Users

6,000-6,500

Aggregate Target Number of PrEP Users from All Projects (Planned and Ongoing)

3,000-3,500

PEPFAR Target in COP 2018

Not available

Types of Delivery Projects

  • Implementation project
  • National health system

*Definitions of types of projects available in the glossary below.

Drug Registration Status

  • Gilead’s Truvada (TDF/FTC) is approved for prevention
  • Generic versions of TDF/FTC are registered for prevention

Research, Demonstration and Implementation Projects

Click here for a full list of ongoing and planned research/demonstration projects in France.

Policy Framework

ANSM Pre-Exposure Prophylaxis Guidelines (2017)

Funding

ANRS, The Bill & Melinda Gates Foundation, Inserm, The Canadian Trial Network, Fondation Pierre Bergé, Gilead Sciences


Eligibility Criteria
Resources for France
Glossary of Terms

Last updated April 16, 2018.

News Spotlight